MACROGENICS INC — Director's Dealing 2023

Feb 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2023-02-15

Reporting Person: Spitznagel Thomas (Sr VP, Technical Ops)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-15	Employee stock option (right to buy)	$4.82	A	170000	Acquired	2033-02-15	Common Stock (170000.0)	Direct
2023-02-15	Restricted Stock Unit	$0.0	A	40000	Acquired		Common Stock (40000.0)	Direct

Footnotes

F1: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.